CA2216139C - Recombinant infectious laryngotracheitis virus and uses thereof - Google Patents

Recombinant infectious laryngotracheitis virus and uses thereof Download PDF

Info

Publication number
CA2216139C
CA2216139C CA2216139A CA2216139A CA2216139C CA 2216139 C CA2216139 C CA 2216139C CA 2216139 A CA2216139 A CA 2216139A CA 2216139 A CA2216139 A CA 2216139A CA 2216139 C CA2216139 C CA 2216139C
Authority
CA
Canada
Prior art keywords
ser
ala
leu
thr
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2216139A
Other languages
English (en)
French (fr)
Other versions
CA2216139A1 (en
Inventor
Martha A. Wild
Mark D. Cochran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD International Holdings GmbH
Original Assignee
MSD International Holdings GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MSD International Holdings GmbH filed Critical MSD International Holdings GmbH
Publication of CA2216139A1 publication Critical patent/CA2216139A1/en
Application granted granted Critical
Publication of CA2216139C publication Critical patent/CA2216139C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA2216139A 1995-03-23 1996-03-21 Recombinant infectious laryngotracheitis virus and uses thereof Expired - Fee Related CA2216139C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41012195A 1995-03-23 1995-03-23
US46819095A 1995-06-06 1995-06-06
US08/468,190 1995-06-06
US08/410,121 1995-06-06
PCT/US1996/003916 WO1996029396A1 (en) 1995-03-23 1996-03-21 Recombinant infectious laryngotracheitis virus and uses thereof

Publications (2)

Publication Number Publication Date
CA2216139A1 CA2216139A1 (en) 1996-09-26
CA2216139C true CA2216139C (en) 2013-01-08

Family

ID=27020873

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2216139A Expired - Fee Related CA2216139C (en) 1995-03-23 1996-03-21 Recombinant infectious laryngotracheitis virus and uses thereof

Country Status (4)

Country Link
EP (1) EP0822980A4 (ja)
JP (1) JP3964458B2 (ja)
CA (1) CA2216139C (ja)
WO (1) WO1996029396A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8821441D0 (en) 1988-09-13 1988-10-12 Animal Health Inst Viral vectors
FR2750866B1 (fr) * 1996-06-27 1998-11-27 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
FR2757061B1 (fr) * 1996-12-16 1999-03-26 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
JP4549188B2 (ja) 2002-09-18 2010-09-22 アメリカ合衆国 組換えヒト2型パラインフルエンザウイルス(HPIV2)のcDNAからの回収(recovery)、並びにPIVおよび他のヒト病原体に対する免疫応答を誘発する免疫原性組成物における、そしてベクターとしての組換えHPIV2の使用
CN103890183A (zh) 2011-10-21 2014-06-25 英特维特国际股份有限公司 编码传染性喉气管炎病毒和新城疫病毒抗原的重组非致病性马立克氏病病毒构建体
EP2768529A1 (en) 2011-10-21 2014-08-27 Intervet International B.V. Recombinant nonpathogenic mdv vector providing multivalent immunity
EP3554536B1 (en) * 2016-12-14 2022-10-26 Boehringer Ingelheim Animal Health USA Inc. Recombinant hvt vectors expressing multiple antigens of avian pathogens, and vaccines comprising them
CN109609468B (zh) * 2018-12-10 2020-06-30 畜科生物工程有限公司 一种六基因缺失的猪伪狂犬病毒、猪伪狂犬病疫苗以及制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002802A2 (en) * 1988-09-13 1990-03-22 Institute For Animal Health Limited Viral nucleotide sequences
WO1991002053A1 (en) * 1989-08-01 1991-02-21 Arthur Webster Pty. Ltd. Low virulence laryngotracheitis (ilt) virus for vaccinating birds
DE69101683T2 (de) * 1990-07-30 1994-07-21 Akzo Nv Rekombinantes Mareks-Krankheitsvirus.
WO1992003554A1 (en) * 1990-08-24 1992-03-05 Arthur Webster Pty. Ltd. Infectious laryngotracheitis virus vaccine
US6087127A (en) * 1990-08-24 2000-07-11 Board Of Trustees Operating Michigan State University Marek's disease herpesvirus DNA segment encoding glycoproteins, gD, gI and gE
WO1995008622A1 (en) * 1993-09-24 1995-03-30 Syntro Corporation Recombinant infectious laryngotracheitis virus and uses thereof

Also Published As

Publication number Publication date
EP0822980A4 (en) 2000-04-26
EP0822980A1 (en) 1998-02-11
AU5369096A (en) 1996-10-08
WO1996029396A1 (en) 1996-09-26
CA2216139A1 (en) 1996-09-26
AU721451B2 (en) 2000-07-06
JP3964458B2 (ja) 2007-08-22
JPH11503009A (ja) 1999-03-23

Similar Documents

Publication Publication Date Title
US7892564B2 (en) Recombinant infectious laryngotracheitis virus and uses thereof
Darteil et al. Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens
AU711815C (en) Recombinant herpesvirus of turkeys and uses thereof
US5853733A (en) Recombinant herpesvirus of turkeys and uses thereof
US5928648A (en) Recombinant herpesvirus of turkeys and uses thereof
US5741696A (en) Recombinant equine herpesviruses
US5961982A (en) Recombinant herpesvirus of turkeys and uses thereof
CA2216139C (en) Recombinant infectious laryngotracheitis virus and uses thereof
US5731188A (en) Recombinant equine herpesviruses
EP0654089B1 (en) Recombinant equine herpesviruses
WO1995008622A1 (en) Recombinant infectious laryngotracheitis virus and uses thereof
US6225111B1 (en) Recombinant equine herpesviruses
AU721451C (en) Recombinant infectious laryngotracheitis virus and uses thereof
AU703321B2 (en) Recombinant infectious bovine rhinotracheitis virus S-IBR-052 and uses thereof
AU6250500A (en) Recombinant infectious laryngotracheitis virus and uses thereof
CA2626498C (en) Recombinant chimeric virus
AU684046C (en) Recombinant herpesvirus of turkeys and uses thereof
AU1349100A (en) Recombinant herpesvirus of turkeys and uses thereof II

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20150323